Hematological findings and complications of COVID‐19 Tập 95 Số 7 - Trang 834-847 - 2020
Evangelos Terpos, Ioannis Ntanasis‐Stathopoulos, Ismaı̈l Elalamy, Efstathios Kastritis, Theodoros Ν. Sergentanis, Marianna Politou, Θεοδώρα Ψαλτοπούλου, Grigoris T. Gerotziafas, Meletios Α. Dimopoulos
AbstractCOVID‐19 is a systemic infection with a significant impact on the
hematopoietic system and hemostasis. Lymphopenia may be considered as a cardinal
laboratory finding, with prognostic potential. Neutrophil/lymphocyte ratio and
peak platelet/lymphocyte ratio may also have prognostic value in determining
severe cases. During the disease course, longitudinal evaluation of lymphocyte
count dyna... hiện toàn bộ
An introduction to chimeric antigen receptor (CAR) T‐cell immunotherapy for human cancer Tập 94 Số S1 - 2019
Steven Feins, Weimin Kong, Erik F. Williams, Michael C. Milone, Joseph A. Fraietta
Chimeric antigen receptor (CAR) T‐cell therapy represents a major advancement in
personalized cancer treatment. In this strategy, a patient's own T cells are
genetically engineered to express a synthetic receptor that binds a tumor
antigen. CAR T cells are then expanded for clinical use and infused back into
the patient's body to attack and destroy chemotherapy‐resistant cancer. Dramatic
clinical ... hiện toàn bộ
Treatment of sinus histiocytosis with massive lymphadenopathy (rosai‐dorfman disease): Report of a case and literature review Tập 69 Số 1 - Trang 67-71 - 2002
Alessandro Pulsoni, Gabriel Anghel, Paolo Falcucci, Roberta Matera, Edoardo Pescarmona, Michela Ribersani, Nicoletta Villivà, Franco Mandelli
AbstractSinus histiocytosis with massive lymphadenopathy (SHML) is a rare
disorder of unknown etiology, usually associated with lymph node enlargement in
various superficial or deep sites. It usually shows a prolonged clinical course
with occasional exacerbation and remission phases. We describe the long‐term
follow‐up of a case of SHML that showed typical clinical features and in which
various th... hiện toàn bộ
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors Tập 87 Số S1 - 2012
Scott Kaatz, Peter A. Kouides, David García, Alex C. Spyropolous, Mark Crowther, Jim Douketis, Anthony Chan, Andra H. James, Stephan Moll, Thomas L. Ortel, Elizabeth M. Van Cott, Jack Ansell
AbstractThe new oral anticoagulants dabigatran, rivaroxaban and apixaban have
advantages over warfarin which include no need for laboratory monitoring, less
drug–drug interactions and less food‐drug interactions. However, there is no
established antidote for patients who are bleeding or require emergent surgery
and there is a paucity of evidence to guide the clinical care during these
situations. ... hiện toàn bộ
Estimated annual numbers of US acute‐care hospital patients at risk for venous thromboembolism Tập 82 Số 9 - Trang 777-782 - 2007
Frederick A. Anderson, Maxim Zayaruzny, John A. Heit, Dogan Fidan, Alexander T. Cohen
AbstractVenous thromboembolism (VTE) is a major US health problem. However, the
total number of US inpatients who are at risk for VTE is unknown. Our objective
was to estimate the number of US acute‐care hospital inpatients who were at risk
for VTE according to criteria established by the Seventh American College of
Chest Physicians (ACCP) Consensus Conference on Antithrombotic and Thrombolytic
Th... hiện toàn bộ
Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML Tập 90 Số 8 - Trang 732-736 - 2015
Courtney D. DiNardo, Farhad Ravandi, Sam Agresta, Marina Konopleva, Koichi Takahashi, Tapan M. Kadia, Mark J. Routbort, Keyur P. Patel, Mark Brandt, Sherry Pierce, Guillermo Garcia‐Manero, Jorge E. Cortés, Hagop M. Kantarjian
The pathophysiology of IDH mutations in tumorigenesis is increasingly described,
yet the prognostic significance of IDH1 and IDH2 mutations in AML remains
controversial. The primary objective of this study was to define the natural
history and prognosis of patients with AML and IDH1 or IDH2 mutations and
provide historical survival expectations. A total of 826 patients treated from
2010 to 2014 at... hiện toàn bộ
Cryopreservation of hematopoietic stem cells Tập 82 Số 6 - Trang 463-472 - 2007
David Berz, Elise McCormack, Eric S. Winer, Gerald A. Colvin, Peter J. Quesenberry
AbstractStem cell transplantation represents a critical approach for the
treatment of many malignant and non‐malignant diseases. The foundation for these
approaches is the ability to cryopreserve marrow cells for future use. This
technique is routinely employed in all autologous settings and is critical for
cord blood transplantation. A variety of cryopreservatives have been used with
multiple fre... hiện toàn bộ
Primary myelofibrosis: 2021 update on diagnosis, risk‐stratification and management Tập 96 Số 1 - Trang 145-162 - 2021
Ayalew Tefferi
AbstractDisease OverviewPrimary myelofibrosis (PMF) is a myeloproliferative
neoplasm (MPN) characterized by stem cell‐derived clonal myeloproliferation that
is often but not always accompanied by JAK2, CALR, or MPL mutations. Additional
disease features include bone marrow reticulin/collagen fibrosis, aberrant
inflammatory cytokine expression, anemia, hepatosplenomegaly, extramedullary
hematopoies... hiện toàn bộ